{"component": "definition", "props": {"groups": [{"snippet_links": [], "size": 10, "snippet": "means [***].", "samples": [{"hash": "5Rf7buiSjht", "uri": "/contracts/5Rf7buiSjht#directed-against", "label": "Strategic Collaboration and License Agreement (Metagenomi Technologies, LLC)", "score": 35.0095825195, "published": true}, {"hash": "kvl3fKbtviI", "uri": "/contracts/kvl3fKbtviI#directed-against", "label": "Option and License Agreement (Inhibrx, Inc.)", "score": 31.5708427429, "published": true}, {"hash": "2oarimkYnj9", "uri": "/contracts/2oarimkYnj9#directed-against", "label": "Option and License Agreement (Inhibrx, Inc.)", "score": 31.4832305908, "published": true}], "hash": "42145ccc68badf480a8ed917c57dd5fc", "id": 1}, {"snippet_links": [{"key": "in-connection-with", "type": "clause", "offset": [15, 33]}, {"key": "the-product", "type": "definition", "offset": [49, 60]}, {"key": "mechanism-of-action", "type": "definition", "offset": [143, 162]}], "size": 7, "snippet": "means, as used in connection with a Target, that the product or agent at issue is designed to interact or bind with such Target as its primary mechanism of action.", "samples": [{"hash": "59VSfwYVP44", "uri": "/contracts/59VSfwYVP44#directed-against", "label": "Collaboration and License Agreement (Allogene Therapeutics, Inc.)", "score": 35.1984939575, "published": true}, {"hash": "eadnIEPiT43", "uri": "/contracts/eadnIEPiT43#directed-against", "label": "Research and Development Collaboration and License Agreement (Hillstream BioPharma Inc.)", "score": 34.5222434998, "published": true}, {"hash": "f7owmssM1hX", "uri": "/contracts/f7owmssM1hX#directed-against", "label": "Collaboration and License Agreement (Allogene Therapeutics, Inc.)", "score": 31.1546878815, "published": true}], "hash": "c931a3d2840678a8c5669fcd1b6c329b", "id": 2}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "licensed-product", "type": "definition", "offset": [29, 45]}, {"key": "in-vivo", "type": "definition", "offset": [55, 62]}, {"key": "gene-editing", "type": "definition", "offset": [63, 75]}, {"key": "contained-in", "type": "definition", "offset": [131, 143]}, {"key": "other-product", "type": "definition", "offset": [174, 187]}, {"key": "add-to", "type": "clause", "offset": [227, 233]}, {"key": "mechanism-of-action", "type": "definition", "offset": [311, 330]}], "size": 4, "snippet": "means, with respect to (a) a Licensed Product or other in vivo gene editing product or therapy and (b) a Target, that the compound contained in such Licensed Product or such other product or therapy is designed or developed to add to, subtract, or modify such Target in a patient\u2019s cells in vivo as its primary mechanism of action.", "samples": [{"hash": "3qqUPHm55j8", "uri": "/contracts/3qqUPHm55j8#directed-against", "label": "Development and License Agreement (Precision Biosciences Inc)", "score": 34.508556366, "published": true}, {"hash": "kPm0GNzrycm", "uri": "/contracts/kPm0GNzrycm#directed-against", "label": "Development and License Agreement (Precision Biosciences Inc)", "score": 32.2087593079, "published": true}, {"hash": "dw8ttkzhdxh", "uri": "https://investor.precisionbiosciences.com/static-files/c2055279-0565-44b6-859b-d6dc716a6bf3", "label": "investor.precisionbiosciences.com", "score": 19.8174686432, "published": false}], "hash": "41c13de8a4d558597b18b9e37a4db5d2", "id": 3}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}, {"key": "contained-in", "type": "definition", "offset": [74, 86]}, {"key": "mechanism-of-action", "type": "definition", "offset": [162, 181]}, {"key": "for-clarity", "type": "clause", "offset": [183, 194]}], "size": 3, "snippet": "means, with respect to a compound or product and a Target, that the Oligo contained in such compound or product binds to and modulates such Target as its primary mechanism of action. For clarity, \u201cDirected Against\u201d requires direct Target interaction, and does not include pathway effects.", "samples": [{"hash": "5EwaeM4cXgj", "uri": "/contracts/5EwaeM4cXgj#directed-against", "label": "Research Collaboration and License Agreement (Atrium Therapeutics, Inc.)", "score": 37.0793991089, "published": true}, {"hash": "kSh6R3UGCXQ", "uri": "/contracts/kSh6R3UGCXQ#directed-against", "label": "Research Collaboration and License Agreement (Avidity Biosciences, Inc.)", "score": 31.3874053955, "published": true}, {"hash": "bEtBEsr3efo", "uri": "/contracts/bEtBEsr3efo#directed-against", "label": "Research Collaboration and License Agreement (Avidity Biosciences, Inc.)", "score": 31.2532520294, "published": true}], "hash": "f7f45a4f7282e399fec5c403a91451d3", "id": 4}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}], "size": 3, "snippet": "means, with respect to a Degrader and a Target, that such Degrader [***].", "samples": [{"hash": "83WWYAOgLcb", "uri": "/contracts/83WWYAOgLcb#directed-against", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "l3SeuC4QJiw", "uri": "/contracts/l3SeuC4QJiw#directed-against", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 34.1444206238, "published": true}, {"hash": "3ebf1sSqNAi", "uri": "/contracts/3ebf1sSqNAi#directed-against", "label": "Collaboration and License Agreement (Kymera Therapeutics, Inc.)", "score": 31.5790557861, "published": true}], "hash": "e10eb9f6ff591eef26926a3dced5322f", "id": 5}, {"snippet_links": [{"key": "with-respect-to-an", "type": "clause", "offset": [7, 25]}, {"key": "other-compound", "type": "definition", "offset": [33, 47]}], "size": 2, "snippet": "means, with respect to an ASO or other compound, and with respect to a particular target, that such ASO or other compound is engineered or selected to modulate such target for therapeutic benefit.", "samples": [{"hash": "hq8JED51i9u", "uri": "/contracts/hq8JED51i9u#directed-against", "label": "License and Collaboration Agreement (Stoke Therapeutics, Inc.)", "score": 33.3531837463, "published": true}, {"hash": "jpxJ9K6jp0I", "uri": "https://investor.stoketherapeutics.com/static-files/01e86a34-06bc-480d-a6c0-b91a5f41d03b", "label": "investor.stoketherapeutics.com", "score": 11.1765909195, "published": false}], "hash": "e6d86c840c6a7da45798f84253cfeda6", "id": 6}, {"snippet_links": [{"key": "in-connection-with", "type": "clause", "offset": [15, 33]}, {"key": "the-product", "type": "definition", "offset": [48, 59]}], "size": 1, "snippet": "means, as used in connection with a [***], that the product or agent at issue is designed to specifically interact or bind with such [***], as applicable.", "samples": [{"hash": "1fgXjA74u4t", "uri": "/contracts/1fgXjA74u4t#directed-against", "label": "Collaboration and License Agreement (CytomX Therapeutics, Inc.)", "score": 34.2320327759, "published": true}], "hash": "03758b33f38b91b53484509e9f67e0d9", "id": 7}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [10, 25]}, {"key": "research-target", "type": "definition", "offset": [61, 76]}], "size": 1, "snippet": "means (a) with respect to a TCER or Collaboration TCER and a Research Target, that such TCER, or Collaboration TCER is [**], or (b) with respect to a TCER Product and a Research Target, at least one Collaboration TCER contained or comprised within such TCER Product is [**].", "samples": [{"hash": "fwknAkIKZwN", "uri": "/contracts/fwknAkIKZwN#directed-against", "label": "Collaboration Project Agreement (Immatics N.V.)", "score": 35.2176589966, "published": true}], "hash": "904c6c54330c900a1489cc48ea632367", "id": 8}, {"snippet_links": [{"key": "in-connection-with", "type": "clause", "offset": [15, 33]}, {"key": "the-product", "type": "definition", "offset": [60, 71]}, {"key": "the-case", "type": "definition", "offset": [150, 158]}], "size": 1, "snippet": "means, as used in connection with a Target and/or CD3, that the product or agent at issue is designed to interact or bind with such Target or CD3, as the case may be.", "samples": [{"hash": "fS9GknmWKOX", "uri": "/contracts/fS9GknmWKOX#directed-against", "label": "Collaboration and License Agreement (CytomX Therapeutics, Inc.)", "score": 31.3463382721, "published": true}], "hash": "894478a512d4ad7e3e413dbb4f9b6483", "id": 9}, {"snippet_links": [{"key": "with-respect-to", "type": "clause", "offset": [7, 22]}], "size": 1, "snippet": "means, with respect to a Target and an ETB or product, that such ETB or product is selected, generated or optimized to preferentially bind to such Target.", "samples": [{"hash": "fpXdZ55NZ82", "uri": "/contracts/fpXdZ55NZ82#directed-against", "label": "Master Collaboration Agreement (Molecular Templates, Inc.)", "score": 31.1957569122, "published": true}], "hash": "468cdf95617cc4c1e912ca6bf0380e7c", "id": 10}], "next_curs": "Cl0SV2oVc35sYXdpbnNpZGVyY29udHJhY3RzcjkLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIZZGlyZWN0ZWQtYWdhaW5zdCMwMDAwMDAwYQyiAQJlbhgAIAA=", "definition": {"size": 39, "title": "Directed Against", "snippet": "means [***].", "id": "directed-against", "examples": ["Once a Collaboration Target becomes a Discontinued Target: (a) all rights and licenses granted under this Agreement will terminate with respect to such Discontinued Target; and (b) either Party may develop and commercialize compounds and products that are <strong>Directed Against</strong> such Discontinued Target at its own cost.", "Each Product and any Compounds contained in such Product that were <strong>Directed Against</strong> such Terminated Target are Terminated Products."], "related": [["attack-directed-against-any-civilian-population", "Attack directed against any civilian population", "Attack <strong>directed against</strong> any civilian population"], ["acute-toxicity", "Acute toxicity", "Acute toxicity"], ["intimidating-threatening-abusive-or-harming-conduct", "Intimidating, threatening, abusive, or harming conduct", "Intimidating, threatening, abusive, or harming conduct"], ["biological-diversity", "Biological diversity", "Biological diversity"], ["opioid-antagonist", "Opioid antagonist", "Opioid antagonist"]], "related_snippets": [], "updated": "2026-02-07T04:24:37+00:00"}, "json": true, "cursor": ""}}